Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this pilot study is to evaluate efficacy and safety of addition of IL-2 to pegylated interferon alpha 2a and ribavirin in HIV-HCV coinfected patients non-responders after three months of standard therapy with pegylated interferon alpha 2a and ribavirin. IL-2 may enhance numbers and function of CD4 T lymphocytes and specific anti-HCV immune responses and could participate to the control of HCV replication
Critère d'inclusion
- HIV Infections ,Chronic hepatitis C